Surgical peri‐implantitis treatment with and without guided bone regeneration. A randomized controlled trial
Clinical Oral Implants Research · 2023
DOI: 10.1111/clr.14116 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, 2023. Verfasst von Lisa J A Heitz-Mayfield und 4 weiteren Autor:innen. Beteiligte Einrichtung: International Research Collaborative, Oral Health and Equity, School of Human Anatomy and Biology, The University of Western Australia, Crawley, West…. Hauptthemen laut MEDLINE: Peri-Implantitis, Dental Implantation, Guided Tissue Regeneration. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Osteology Foundation.
Abstract (Originalsprache)
Objective
To evaluate the efficacy of reconstructive peri‐implantitis treatment. Materials and Methods Forty participants, with peri‐implantitis and a contained intraosseous defect, were randomized to access flap (control) or access flap with xenograft and collagen membrane (test). All received systemic antimicrobials. Blinded examiners recorded probing depths (PD), bleeding and suppuration on probing (BOP & SOP), soft tissue levels, and marginal bone levels (MBL) at baseline and 12 months. Patient reported outcomes were recorded. The primary outcome was PD change.
Results
All 40 participants (40 implants) completed the 12‐month study. The mean (standard deviation) PD reduction (deepest site) was 4.2 (1.8) mm in the control and 3.7 (1.9) mm in the test group. MBL gain (deepest site) was 1.7 (1.6) mm in the control and 2.4 (1.4) mm in the test group. Absence of BOP & SOP was observed at 60% of both control and test implants. Buccal recession was 0.9 (1.6) mm in the control and 0.4 (1.1) mm in the test group. A successful outcome (absence of PD ≥ 5 mm with BOP, absence of SOP and absence of progressive bone loss) was achieved for 90% of the control and 85% of test group implants. No statistically significant differences in clinical or radiographic parameters were found between treatment groups. 30% of participants experienced mild gastro‐intestinal disturbances. Reporting followed CONSORT guidelines.
Conclusion
Similar clinical and radiographic improvements at 12 months were observed with high levels of patient satisfaction for both the access flap and xenograft covered by collagen membrane groups. Registered clinical trials.gov . ID:NCT03163602 (23/05/2017).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Research Collaborative, Oral Health and Equity, School of Human Anatomy and Biology, The University of Western Australia, Crawley, Western Australia, Australia.
- Faculty of Medicine and Health, School of Dentistry, The University of Sydney, Sydney, New South Wales, Australia.
- Perth Periodontal Specialists, West Leederville, Western Australia, Australia.
- Envision Medical Imaging, Wembley, Western Australia, Australia.
- Institute for Health Research, The University of Notre Dame, Fremantle, Western Australia, Australia.
- School of Medical and Health Sciences, ECU, Joondalup, Western Australia, Australia.
ORCID-Profile: Lisa J A Heitz-Mayfield, Paola Chivers
Förderung
- Osteology Foundation
Zitieren
APA
Heitz-Mayfield, L. J. A., Heitz, F., Koong, B., Huang, T., & Chivers, P. (2023). Surgical peri‐implantitis treatment with and without guided bone regeneration. A randomized controlled trial. Clinical Oral Implants Research. https://doi.org/10.1111/clr.14116
Vancouver
Heitz-Mayfield LJA, Heitz F, Koong B, Huang T, Chivers P. Surgical peri‐implantitis treatment with and without guided bone regeneration. A randomized controlled trial. Clinical Oral Implants Research. 2023. doi:10.1111/clr.14116
BibTeX
@article{HeitzMayfield2023,
author = {Heitz-Mayfield, Lisa J A and Heitz, Fritz and Koong, Bernard and Huang, Tom and Chivers, Paola},
title = {Surgical peri‐implantitis treatment with and without guided bone regeneration. A randomized controlled trial},
journal = {Clinical Oral Implants Research},
year = {2023},
doi = {10.1111/clr.14116}
}
EUVIMED